Logo - springer
Slogan - springer

Biomedical Sciences - Neuroscience | Current Trends in Monoclonal Antibody Development and Manufacturing

Current Trends in Monoclonal Antibody Development and Manufacturing

Shire, S.J., Gombotz, W., Bechtold-Peters, K., Andya, J. (Eds.)

2010, XIV, 354 p.

Available Formats:
eBook
Information

Springer eBooks may be purchased by end-customers only and are sold without copy protection (DRM free). Instead, all eBooks include personalized watermarks. This means you can read the Springer eBooks across numerous devices such as Laptops, eReaders, and tablets.

You can pay for Springer eBooks with Visa, Mastercard, American Express or Paypal.

After the purchase you can directly download the eBook file or read it online in our Springer eBook Reader. Furthermore your eBook will be stored in your MySpringer account. So you can always re-download your eBooks.

 
$119.00

(net) price for USA
valid until March 31, 2015

ISBN 978-0-387-76643-0

digitally watermarked, no DRM

Included Format: PDF and EPUB

download immediately after purchase


learn more about Springer eBooks

add to marked items

$239.00
Hardcover
Information

Hardcover version

You can pay for Springer Books with Visa, Mastercard, American Express or Paypal.

Standard shipping is free of charge for individual customers.

 
$159.00

(net) price for USA
valid until March 31, 2015

ISBN 978-0-387-76642-3

free shipping for individuals worldwide

usually dispatched within 3 to 5 business days


add to marked items

$299.00
Softcover
Information

Softcover (also known as softback) version.

You can pay for Springer Books with Visa, Mastercard, American Express or Paypal.

Standard shipping is free of charge for individual customers.

 
$159.00

(net) price for USA
valid until March 31, 2015

ISBN 978-1-4614-2491-8

free shipping for individuals worldwide

usually dispatched within 3 to 5 business days


add to marked items

$299.00
  • Covers one of the fastest growing areas of new drug development within the pharmaceutical industry
  • Offers insight on monoclonal antibodies, products that will become increasingly prevalent over the next decade
  • Describes what is currently being done in the industry to develop, manufacture, and release monoclonal antibody products
  • Explains what will be required for a successful regulatory submission

Monoclonal antibodies represent one of the fastest growing areas of new drug development within the pharmaceutical industry. Several blockbuster products have been approved over the past several years including Rituxan, Remicade, Avastin, Humira, and Herceptin. In addition, over 300 new drugs are currently in clinical trials. With both large, established biotechnology companies and small start-ups involved in the development of this important class of molecules, monoclonal antibodies products will become increasingly prevalent over the next decade.

Recently the regulatory review of monoclonal antibodies has been moved from Center for Biologics and Research to the Center for Drug Evaluation and Research (CDER) division of the US Food and Drug Administration. It is anticipated that CDER will expect a certain minimal amount of data to be provided as more of these products move through the regulatory pipeline. Current Trends in Monoclonal Antibody Development and Manufacturing will provide readers with an understanding of what is currently being done in the industry to develop, manufacture, and release monoclonal antibody products and what will be required for a successful regulatory submission.

Content Level » Professional/practitioner

Keywords » Antibodies - Antigen - Aspects - Monoclonal - Pharmaceutical - Shire

Related subjects » Neuroscience - Pharmacology & Toxicology

Table of contents / Preface / Sample pages 

Popular Content within this publication 

 

Articles

Read this Book on Springerlink

Services for this book

New Book Alert

Get alerted on new Springer publications in the subject area of Neurosciences.